Umoja Biopharma

Umoja Biopharma

Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patients with cancer have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.

Departments (10)
Offices (3)
6
open right now
3
hiring across
0
added or updated in 24h
0
hiring from anywhere
6  positions
Umoja Biopharma
Associate Director, Clinical and Statistical Programming
Umoja Biopharma
Seattle, Washington, Uni... Healthcare / Medical 1mo ago
Umoja Biopharma
Senior Clinical Trial Manager
Umoja Biopharma
Remote; Seattle, Washing... Healthcare / Medical 1mo ago
Umoja Biopharma
Scientist, Analytical Development
Umoja Biopharma
Seattle, Washington, Uni... Research / Science 1mo ago
Umoja Biopharma
Senior Director, Clinical Data Management
Umoja Biopharma
Louisville, Colorado, Un... Healthcare / Medical 2mos ago
Umoja Biopharma
Senior Medical Director
Umoja Biopharma
Seattle, Washington, Uni... Healthcare / Medical 2mos ago
Umoja Biopharma
Senior Director, Clinical Regulatory Affairs
Umoja Biopharma
Louisville, Colorado, Un... Legal / Compliance 2mos ago

Pick a job to read the details

Tap any role on the left — its description and apply link will open here.

🤖

Whoa — hold up

JobsRadar was built for real people having a rough time in their job search — not for automated requests. You're clicking way too fast and you're now temporarily blocked.

Come back later. If you're genuinely job hunting, we've got your back — just act like a human.

Catch your next role the second it’s posted.

Create a free account and we’ll watch the boards for you — the instant a job matches your search, it lands in your inbox or Telegram. No digging, no refreshing.

Create free account

Free forever · takes 30 seconds · already have one?

Don't be the 201st applicant.

Every worldwide-remote role pushed to our Telegram the moment it goes live. Subscribers apply hours before this page even refreshes.

Subscribe — it's free